​

GridAI Technologies Stock (NASDAQ:GRDX)

RevenueOwnershipFinancialsChart
GridAI Technologies by TradingView

Previous Close

$3.43

52W Range

$1.87 - $6.93

50D Avg

$3.35

200D Avg

$3.38

Market Cap

$11.67M

Avg Vol (3M)

$96.93K

Beta

1.88

Div Yield

-

GRDX Company Profile

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

GB

Employees

2

IPO Date

Oct 11, 2016

Website

GRDX Performance

GRDX Financial Summary

Dec 25Dec 24Dec 23
Revenue$36.25K--
Operating Income$-7.08M$-15.62M$-15.77M
Net Income$-6.55M$-18.06M$-15.79M
EBITDA$-7.08M$-15.57M$-15.74M
Basic EPS$-4.16$-3.88$-46.96
Diluted EPS$-4.16$-5.33$-46.96

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

TickerCompany
CRISCuris, Inc.
ALLRAllarity Therapeutics, Inc.
ASBPAspire Biopharma Holdings, Inc.
CINGCingulate Inc.
CTXRCitius Pharmaceuticals, Inc.
BCTXBriaCell Therapeutics Corp.
PCSAProcessa Pharmaceuticals, Inc.
ATHAAthira Pharma, Inc.
LPTXLeap Therapeutics, Inc.
PALIPalisade Bio, Inc.